Noninvasive Peripheral Nerve Stimulation for Medication-Refractory Primary RLS (The RESTFUL Study)

NCT04874155 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

133

Enrollment

INDUSTRY

Sponsor class

Conditions

Restless Legs Syndrome

Interventions

DEVICE: NTX100 Neuromodulation System - Active
DEVICE: NTX100 Neuromodulation System - Sham
DEVICE: NTX100 Neuromodulation System - Open-Label

Sponsor

Noctrix Health, Inc.